Pfizer and the Challenges of the Pharmaceutical Industry (B) (Simplified Chinese Version)
(4 pages of text)
Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.
After working through the assignment questions for Case B, students will be able to do the following:
- Analyze how pharmaceutical companies strategically respond to changes in the industry.
- Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).
- Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.
- Identify, analyze, and evaluate relevant data and information.
Health Care Services
United States, Large, 2018
$3.15 CAD / $3.10 USD Printed Copy
$2.65 CAD / $2.62 USD Permissions
$2.65 CAD / $2.62 USD Digital Download